Gore Receives FDA Approval for the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System
The innovative device and delivery system combine proven conformability with new levels of control.
Jan 6, 2021
The innovative device and delivery system combine proven conformability with new levels of control.
Jan 6, 2021
At the American Heart Association Virtual Scientific Sessions 2020.
Nov 18, 2020
Improvements to large diameter devices include accessiblity through smaller sheaths while providing enhanced visualization under fluoroscopy
Sep 22, 2020
As liver disease prevalence grows worldwide, earlier TIPS intervention with the GORE® VIATORR® TIPS Endoprosthesis has proven to increase survival and to reduce complications of liver cirrhosis over conventional therapies.1
Aug 25, 2020
May 11, 2020
Analysis of the Gore REVISE Clinical Study data examined reinterventions and associated costs to maintain dialysis access in thrombosed and stenotic circuits.
May 1, 2020
CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success
Oct 2, 2019
Gore furthers its commitment to patient-centered cardiac innovation
Sep 26, 2019
U.S. pivotal study will determine safety and effectiveness of modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels
Jul 18, 2019
Designation recognizes products that bring improvements to the health care industry
Jul 17, 2019